Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE)
Funds preclinical research on how radiation from cancer radiopharmaceuticals affects tumors and normal tissue, as a short or a long project.
Radiopharmaceutical therapy treats cancer with radiation delivered by a targeting molecule, and understanding how that radiation actually affects tissue — tumor and healthy alike — is what decides whether the next generation of these treatments works better or just differently. This notice funds that understanding at the preclinical stage.
The named goal is mechanistic: how different forms of rad…
Preclinical cancer-biology research on the biological effects of radionuclide-emitted radiation used in radiopharmaceutical therapy — how it affects normal tissue, tumor cells and the tumor microenvironment — integrating cancer biology, radiation biology, radiochemistry, imaging, dosimetry and preclinical modeling, as either an exploratory/developmental project of up to 2 years or a research project of 4 to 5 years.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up